Cargando…
Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043571/ https://www.ncbi.nlm.nih.gov/pubmed/36999005 http://dx.doi.org/10.1097/HS9.0000000000000870 |
| _version_ | 1784913183490703360 |
|---|---|
| author | Tam, Constantine Munoz, Javier Cull, Gavin Opat, Stephen Allewelt, Heather Zhang, Xiaoping Stern, Jennifer C. Hilger, James By, Kunthel Cohen, Aileen Tedeschi, Alessandra |
| author_facet | Tam, Constantine Munoz, Javier Cull, Gavin Opat, Stephen Allewelt, Heather Zhang, Xiaoping Stern, Jennifer C. Hilger, James By, Kunthel Cohen, Aileen Tedeschi, Alessandra |
| author_sort | Tam, Constantine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10043571 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100435712023-03-29 Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia Tam, Constantine Munoz, Javier Cull, Gavin Opat, Stephen Allewelt, Heather Zhang, Xiaoping Stern, Jennifer C. Hilger, James By, Kunthel Cohen, Aileen Tedeschi, Alessandra Hemasphere Letter Lippincott Williams & Wilkins 2023-03-24 /pmc/articles/PMC10043571/ /pubmed/36999005 http://dx.doi.org/10.1097/HS9.0000000000000870 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Tam, Constantine Munoz, Javier Cull, Gavin Opat, Stephen Allewelt, Heather Zhang, Xiaoping Stern, Jennifer C. Hilger, James By, Kunthel Cohen, Aileen Tedeschi, Alessandra Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia |
| title | Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia |
| title_full | Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia |
| title_fullStr | Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia |
| title_full_unstemmed | Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia |
| title_short | Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia |
| title_sort | zanubrutinib, alone and in combination with tislelizumab, for the treatment of richter transformation of chronic lymphocytic leukemia |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043571/ https://www.ncbi.nlm.nih.gov/pubmed/36999005 http://dx.doi.org/10.1097/HS9.0000000000000870 |
| work_keys_str_mv | AT tamconstantine zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia AT munozjavier zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia AT cullgavin zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia AT opatstephen zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia AT alleweltheather zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia AT zhangxiaoping zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia AT sternjenniferc zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia AT hilgerjames zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia AT bykunthel zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia AT cohenaileen zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia AT tedeschialessandra zanubrutinibaloneandincombinationwithtislelizumabforthetreatmentofrichtertransformationofchroniclymphocyticleukemia |